Day 2 Agenda
Use the links below to navigate the Life Sciences Future Conference!
Click Below to Download the 2025 Agenda
2026 Day 2 Agenda Preview
8:00am - 9:00am Breakfast
Sponsored by: Cytivia
8:00am - 8:45am Breakfast in the C Suite (Invite-Only)
This session offers a unique opportunity to hear directly from industry leader investor, Dennis Purcell, Aisling Capital, on the life sciences funding landscape, qualities investors are looking for in emerging companies and how you can better position yourself for success.
Breakfast in the C Suite is invite-only for R&D, research institutions, pharmaceutical, med tech, and biotech C level executives. Please contact Emily Boring (eboring@lifesciencespa.org) if you are unsure of your eligibility.
Speaker:
Dennis Purcell, Founder & Senior Advisor, Aisling Capital
Moderator: Rachael Bushey, Life Sciences Partner & Co-Chair, Philadelphia Office, Goodwin
Breakfast in the C Suite Sponsored by: PwC and Goodwin
9:00am - 10:00am Welcome Remarks & International Clinical Trials and Dealmaking – A One-Way Street or an Exchange of Opportunity?
Clinical research and deals are increasingly crossing borders, creating new opportunities and challenges for the life sciences industry. This panel will explore the benefits, tradeoffs, and lessons learned from conducting global clinical trials. Hear perspectives from large and emerging biopharma companies and policymakers as they discuss how international clinical research and dealmaking are driving innovation, improving efficiencies, and shaping the future of drug development.
Speakers:
Chong Xu, Partner, F-Prime Capital
Hugh Davis, PhD, Chief Operating Officer & President, Aclaris Therapeutics
Location: Grand Ballroom
Sponsored by: Ballard Spahr
11:30am - Lunch
12:00pm - 12:45pm Fireside Chat with Dr. Marty Makary
From leadership transitions to evolving regulatory guidance, the FDA is navigating a period of significant transformation. Hear from 27th Commissioner of the FDA, Dr. Marty Makary, as he takes the stage to discuss how the latest policy developments and operational shifts are impacting the life sciences ecosystem. Learn how these changes can affect your company and receive the latest insights and updates from experts at the forefront.
Speaker:
Marty Makary, MD, MPH, 27th Commissioner of the FDA
Moderated by: Mike Goodman, Shareholder, Brownstein
Location: Grand Ballroom
Sponsored by: Brownstein
1:45pm - 2:30pm From Discovery to Breakthroughs: The Transformation of GLP-1’s
GLP-1 therapies have transformed the healthcare landscape, driving one of the most impactful market shifts in recent years. This session offers insights from industry leaders as they discuss the evolution of GLP-1 therapies, opportunities and challenges that companies are facing and how new innovations and the broader cultural milieu will influence the next generation of discovery.
Speaker:
Raj Kannan, CEO, Alveus Therapeutics
Moderated by: Rebecca Guzman, Partner, Duane Morris
Location: Grand Ballroom
Sponsored by: Duane Morris
Thank you to our 2026 event sponsors
Interested in sponsoring Life Sciences Future? Please contact Gabi Forgione (gforgione@lifesciencespa.org) for sponsorship inquiries.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.